At a glance
ClinicalIndex Comparison RecordN/ACompleted· 166 enrolled
Drug / intervention
B&L Investigational Contact Lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Evaluate the Safety and Efficacy of a New Silicone Hydrogel Contact Lens Design
In Brief
A clinical study evaluating B&L Investigational Contact Lens and B&L PureVision Contact Lens for Myopia. Completed, enrolled 166 participants.
Detailed Summary
The objective of this study is to evaluate the safety and efficacy of a new silicone hydrogel contact lens compared to the Bausch + Lomb PureVision contact lens when worn by adapted soft contact lens wearers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
First PostedOct 2011
Primary CompletionDec 2011
Study CompletionJan 2012
TodayJul 2026
First PostedOct 10, 2011
Enrollment StartAug 1, 2011
Primary CompletionDec 1, 2011
Study CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 14.7 years ago
Interventions
B&L Investigational Contact Lensdevice
Lenses will be worn on a daily wear basis for 3 months, new lenses dispensed monthly.
B&L PureVision Contact Lensdevice
Lenses will be worn on a daily wear basis for 3 months, new lenses dispensed monthly.